Toby Richardson | AIChE

Toby Richardson

Denovium (now part of ABSci)

Toby brings over two decades of experience leading bioinformatics teams, and developing products and commercializing genomics software. Toby spent ten years at Diversa Corporation, where he successfully isolated and evolved industrially useful enzymes, one of which was commercialized to produce ethanol by Syngenta “Enogen”.

He also ran and managed an enzymology and informatics group and his team developed some of the first tools to annotate, store, and mine large metagenomic datasets from environmental samples. Toby then went to Synthetic Genomics Inc. (SGI) and served as VP of Informatics. He was responsible for setting up the informatics and software engineering departments and led the development and implementation of SGIs proprietary genomics software platform Archetype®.

In 2018, Toby co-founded Denovium an AI company specializing in using deep learning technology for protein discovery, evolution and de-novo design of proteins. Denovium was acquired in early 2021 by the synthetic biology company ABSci who are integrating the Denovium engine into their Protein Printing platform.

Toby holds a Biochemistry degree and PhD from the University of Surrey, England. He is the author of more than 30 peer reviewed publications and is an inventor on more than 20 patents.

Google Scholar: